• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核磁共振(NMR)与高通量筛选的整合

Integration of NMR and high-throughput screening.

作者信息

Hajduk Philip J, Burns David J

机构信息

Global Pharmaceutical Research and Development, Abbott Park, IL 60064, USA.

出版信息

Comb Chem High Throughput Screen. 2002 Dec;5(8):613-21. doi: 10.2174/1386207023329996.

DOI:10.2174/1386207023329996
PMID:12470258
Abstract

NMR-based screening has become a powerful method for the identification and analysis of low-molecular weight organic compounds that bind to protein targets and can be utilized in drug discovery programs. In particular, heteronuclear NMR-based screening can yield information about both the affinity and binding location of potential lead compounds. In addition, heteronuclear NMR-based screening has wide applications in complementing and facilitating conventional high-throughout screening programs. This article will describe several strategies for the integration of NMR-based screening and high-throughput screening. The marriage of these two techniques promises to be of tremendous benefit in the triage of hits that come from HTS, and can aid the medicinal chemist in the identification of quality leads that have high potential for further optimization.

摘要

基于核磁共振(NMR)的筛选已成为一种强大的方法,用于识别和分析与蛋白质靶点结合的低分子量有机化合物,并可用于药物发现项目。特别是,基于异核NMR的筛选能够产生有关潜在先导化合物的亲和力和结合位置的信息。此外,基于异核NMR的筛选在补充和促进传统高通量筛选项目方面具有广泛应用。本文将描述几种将基于NMR的筛选与高通量筛选相结合的策略。这两种技术的结合有望在对高通量筛选产生的命中物进行分类方面带来巨大益处,并有助于药物化学家识别具有进一步优化高潜力的优质先导物。

相似文献

1
Integration of NMR and high-throughput screening.核磁共振(NMR)与高通量筛选的整合
Comb Chem High Throughput Screen. 2002 Dec;5(8):613-21. doi: 10.2174/1386207023329996.
2
Application of NMR screening in drug discovery.核磁共振筛选在药物发现中的应用。
Curr Top Med Chem. 2003;3(1):81-97. doi: 10.2174/1568026033392796.
3
Applications of SHAPES screening in drug discovery.SHAPES筛选在药物发现中的应用。
Comb Chem High Throughput Screen. 2002 Dec;5(8):583-90. doi: 10.2174/1386207023329950.
4
NMR screening in fragment-based drug design: a practical guide.基于片段的药物设计中的核磁共振筛选:实用指南。
Methods Mol Biol. 2015;1263:197-208. doi: 10.1007/978-1-4939-2269-7_16.
5
Affinity-based screening techniques for enhancing lead discovery.用于加强先导化合物发现的基于亲和力的筛选技术。
Curr Opin Drug Discov Devel. 2004 Jul;7(4):411-6.
6
High impact technologies for natural products screening.用于天然产物筛选的高影响力技术。
Prog Drug Res. 2008;65:175, 177-210. doi: 10.1007/978-3-7643-8117-2_5.
7
NMR-based approaches for lead discovery.基于核磁共振的先导化合物发现方法。
Curr Opin Drug Discov Devel. 2002 Jul;5(4):630-47.
8
NMR-based screening methods for lead discovery.基于核磁共振的先导化合物发现筛选方法。
EXS. 2003(93):183-202. doi: 10.1007/978-3-0348-7997-2_9.
9
Utility of NMR in lead optimization: fragment-based approaches.核磁共振在先导化合物优化中的应用:基于片段的方法。
Comb Chem High Throughput Screen. 2002 Dec;5(8):631-43. doi: 10.2174/1386207023329941.
10
NMR and in silico screening.核磁共振(NMR)及计算机模拟筛选
Comb Chem High Throughput Screen. 2002 Dec;5(8):591-603. doi: 10.2174/1386207023329987.

引用本文的文献

1
Mechanistic enzymology in drug discovery: a fresh perspective.药物发现中的机制酶学:全新视角。
Nat Rev Drug Discov. 2018 Feb;17(2):115-132. doi: 10.1038/nrd.2017.219. Epub 2017 Dec 1.
2
Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes.用于开发针对与2型糖尿病相关的胰岛淀粉样多肽聚集的蛋白水解稳定的N-甲基化肽抑制剂。
Interface Focus. 2017 Dec 6;7(6):20160127. doi: 10.1098/rsfs.2016.0127. Epub 2017 Oct 20.
3
Solution NMR Spectroscopy in Target-Based Drug Discovery.
基于靶点的药物发现中的溶液核磁共振波谱法。
Molecules. 2017 Aug 23;22(9):1399. doi: 10.3390/molecules22091399.
4
Identification of Small-Molecule Inhibitors of the HuR/RNA Interaction Using a Fluorescence Polarization Screening Assay Followed by NMR Validation.使用荧光偏振筛选测定法鉴定HuR/RNA相互作用的小分子抑制剂并通过核磁共振验证
PLoS One. 2015 Sep 21;10(9):e0138780. doi: 10.1371/journal.pone.0138780. eCollection 2015.
5
Identifications small molecules inhibitor of p53-mortalin complex for cancer drug using virtual screening.利用虚拟筛选鉴定用于癌症药物的p53- mortalin复合物小分子抑制剂。
Bioinformation. 2012;8(9):426-9. doi: 10.6026/97320630008426. Epub 2012 May 15.
6
Adaptation of high-throughput screening in drug discovery-toxicological screening tests.高通量筛选在药物发现中的应用——毒理学筛选试验。
Int J Mol Sci. 2012;13(1):427-52. doi: 10.3390/ijms13010427. Epub 2011 Dec 29.
7
Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease.小分子抑制剂抑制淀粉样β肽聚集作为阿尔茨海默病的潜在治疗策略。
Acta Pharmacol Sin. 2011 May;32(5):545-51. doi: 10.1038/aps.2011.14. Epub 2011 Apr 18.
8
Application of isothermal titration calorimetry and column chromatography for identification of biomolecular targets.应用等温滴定量热法和柱层析技术鉴定生物分子靶标。
Nat Protoc. 2011 Feb;6(2):158-65. doi: 10.1038/nprot.2010.187. Epub 2011 Jan 20.
9
Screening of small molecule interactor library by using in-cell NMR spectroscopy (SMILI-NMR).利用细胞内核磁共振光谱法(SMILI-NMR)筛选小分子相互作用体文库。
J Med Chem. 2009 Jun 11;52(11):3516-22. doi: 10.1021/jm9000743.
10
Perspectives on NMR in drug discovery: a technique comes of age.药物研发中核磁共振技术的展望:一项技术走向成熟
Nat Rev Drug Discov. 2008 Sep;7(9):738-45. doi: 10.1038/nrd2606.